Bio Therapeutic Drugs Company Investment Opportunity in Gurgaon, India

Cancer immunotherapy based research & medicine manufacturing company based out of Gurgaon.
This Business is on a Premium Plan
Investment Note
GST Certificate
Established From
Employees
Legal Entity
Reported Sales
Run Rate Sales
USD 250 thousand
EBITDA Margin
20 - 30 %
Locations
Local Time
2:07 PM New Delhi
Listed By
Management Member
Status
Moderately Active
Overall Rating
Seeking Investment
USD 17 million for 26.0% stake (Native Currency: INR 1,200,000,000)
Reason: Immediate Term: - The company intends to set up a 35,000 ft2 laboratory to manufacture 120,000 dose... View More
Includes physical assets worth USD 370 thousand
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Business Overview

- Business came into existence in the year 2010 with a vision to find the roots of cancer and to improve the quality of life by immunology based Dendritic cell-based therapy.

- Company aims to provide an economical and effective method of DC immunotherapy in India.

- We received the Indian FDA approval to manufacture / market immunotherapy treatment-related medicines for cancer in India in Dec 2017. We started selling medicines from April 2018.

- Tie-ups with various hospitals, oncologists and Government health schemes for the supply of products in Delhi NCR region.

- We prepare custom-made medicine for each & every patient. So the production number depends upon the requirements from customers.

- Company launched Phase II clinical trials across 7 hospitals in India where it treated 51 patients.

- We have the capacity to treat 600 patients on an annual basis. The company was conferred with the Excellence award for DC clinical trial at UAE Cancer Congress at Dubai.

- Company would start making profits in the near future. Last our sales was only from the research work. This year sale of medicines too helped in revenue generation. We will continue to see this improving.

- Promoter1: A visionary entrepreneur, responsible for developing dendritic cell immunotherapy at a commercial scale in India.

- Promoter2: A first generation entrepreneur responsible for bringing the cellular therapies in India.

Products & Services Overview

- Developed a unique patented technology to load antigen on Dendritic Cells matured from a patient's own monocytes.

- Filed another patent in June 2017 to decrease the effects of an inhibitory molecule.

Facilities Overview
Recent Activity
  • 5 days, 15 hours ago
    Executive Director, New Delhi, Financial Advisor connected with this business
  • 1 week, 6 days ago
    Assistant Vice President, Mumbai, Financial Advisor connected with this business
  • Earlier than 15 days
    Analyst, Mumbai, Financial Advisor connected with this business
Disclaimer: SMERGERS is a marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
Disclaimer: SMERGERS is a marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses

Frequently
Asked
Questions

  • Why can’t I see the business’ name or contact number? How do I contact the business?
  • What level of due diligence does SMERGERS conduct on the businesses/member?
  • How can I be sure that the business profile will be active?
  • How does SMERGERS rate business profiles?
  • Do I need to pay to connect with a business?
  • Show more